SPAC56F8.13 Antibody

What is SPAC16E8.13 and what cellular function does it perform?

SPAC16E8.13 encodes a RING finger protein ETP1 homolog (also known as BRAP2 homolog) in Schizosaccharomyces pombe (fission yeast). The protein has a molecular weight of approximately 61,825 Da and may act as a cytoplasmic retention protein with a role in regulating nuclear transport . The protein contains specific domains that allow it to function in protein-protein interactions and potentially in ubiquitin-protein ligase E3 activity, as predicted by sequence analysis . Understanding its function is important for researchers studying nuclear-cytoplasmic trafficking and related cellular processes in S. pombe.

What types of SPAC16E8.13 antibodies are commercially available for research?

Based on available information, researchers can access polyclonal antibodies against SPAC16E8.13, such as Rabbit anti-Schizosaccharomyces pombe SPAC16E8.13 Polyclonal Antibody . These antibodies are typically produced by immunizing rabbits with recombinant Schizosaccharomyces pombe SPAC16E8.13 protein and then purifying the antibodies through antigen-affinity methods . They are provided in liquid format, often with preservatives such as Proclin 300 and stabilizers like glycerol in PBS buffer . These antibodies are specifically designed for research applications and are not intended for diagnostic procedures.

What applications are SPAC16E8.13 antibodies suitable for?

SPAC16E8.13 antibodies have been tested and found suitable for specific laboratory applications including:

• Western Blot (WB): For detection of the protein in cell lysates and tissue homogenates

• ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection in solution

Researchers should be aware that optimal dilutions must be determined empirically for each specific application and experimental system. The antibodies are designed for research use only and should not be used in diagnostic procedures or therapeutic applications .

How should SPAC16E8.13 antibodies be stored and handled for optimal performance?

For optimal performance and longevity, SPAC16E8.13 antibodies should be:

• Stored at -20°C to -70°C upon receipt for long-term storage (up to 12 months)

• For short-term storage (up to 1 month), keep at 2-8°C under sterile conditions after reconstitution

• Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt

• If the antibody vial contents become trapped in the seal during shipment, briefly centrifuge the vial to dislodge any liquid in the container's cap

• Always maintain sterile conditions when handling the antibody to prevent contamination

What strategies can improve the efficiency of genetic manipulations involving SPAC16E8.13 in S. pombe?

When targeting genes like SPAC16E8.13 in S. pombe, researchers often face challenges with transformation efficiency. For improved results:

• Consider using the modified transformation procedure described in recent literature, which can increase transformation efficiency up to 5-fold when using antibiotic-based dominant selection markers .

• For particularly difficult loci, removal of the pku70+ and pku80+ genes (which encode DNA end binding proteins required for non-homologous end joining DNA repair) can significantly improve homologous recombination efficiency .

• Design longer homology arms (500-1000 bp) flanking your target region to increase the probability of successful homologous recombination.

• Optimize the selection method based on your specific experimental design; antibiotic resistance markers may perform differently depending on the genomic context.

How can researchers validate SPAC16E8.13 antibody specificity in S. pombe studies?

Validation of antibody specificity is crucial for reliable results. For SPAC16E8.13 antibodies, consider implementing these validation strategies:

• Knockout Controls: Generate SPAC16E8.13 deletion strains to serve as negative controls. The absence of signal in these strains confirms antibody specificity .

• Epitope Tagging: Create strains expressing tagged versions of SPAC16E8.13 (e.g., with GFP or FLAG) and confirm co-localization of antibody signal with the tag using a separate detection system .

• Peptide Competition Assays: Pre-incubate the antibody with excess purified antigen or immunizing peptide before application. Specific signals should be significantly reduced or eliminated.

• Cross-Reactivity Assessment: Test the antibody against related proteins, particularly other RING finger proteins in S. pombe, to ensure it doesn't cross-react with similar epitopes.

• Multiple Antibody Validation: Where possible, use antibodies raised against different epitopes of SPAC16E8.13 and compare detection patterns.

What are the optimal conditions for immunoprecipitation studies using SPAC16E8.13 antibodies?

For successful immunoprecipitation of SPAC16E8.13 and its interaction partners:

• Cell Lysis Buffer Selection: Use a buffer that maintains protein interactions while effectively lysing S. pombe cells. A typical buffer might contain 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, supplemented with protease inhibitors.

• Antibody Binding Optimization:

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

  • Incubate antibody with lysate at 4°C overnight with gentle rotation

  • For weak interactions, consider chemical crosslinking approaches

• Washing Conditions: Balance between stringency to reduce background and gentleness to maintain specific interactions. Typically 3-5 washes with decreasing salt concentrations.

• Elution Methods: Compare different elution strategies (glycine pH 2.5, SDS buffer, or competitive elution with the immunizing peptide) to determine which provides the cleanest results with minimal antibody contamination.

• Controls: Always include a non-specific IgG control and, when possible, a sample from SPAC16E8.13 knockout cells to identify non-specific interactions .

How can ChIP-seq be optimized for studying SPAC16E8.13 binding sites in the S. pombe genome?

Based on approaches used for other S. pombe proteins, a ChIP-seq protocol for SPAC16E8.13 should consider:

• Crosslinking Optimization: Test different formaldehyde concentrations (typically 1-3%) and incubation times (5-20 minutes) to identify conditions that effectively capture protein-DNA interactions without over-crosslinking.

• Sonication Parameters: Optimize sonication conditions to generate DNA fragments of 200-500 bp, which is ideal for downstream sequencing. This typically requires empirical testing with different numbers of cycles and power settings.

• Antibody Selection: The polyclonal antibody against SPAC16E8.13 should be validated for ChIP applications specifically. If performance is suboptimal, consider creating epitope-tagged strains .

• Library Preparation: Follow best practices for preparing ChIP-seq libraries, including adequate controls:

  • Input DNA control (non-immunoprecipitated)

  • Non-specific IgG control

  • Ideally, a SPAC16E8.13 deletion strain as negative control

• Data Analysis Pipeline: Implement robust computational analysis including quality control, read mapping, peak calling, and motif identification. This approach has been successful in identifying binding sites for other S. pombe transcription factors, such as Zas1 .

How can non-specific background be reduced in Western blots using SPAC16E8.13 antibodies?

When experiencing high background in Western blots:

• Blocking Optimization: Test different blocking agents:

  • 5% non-fat dry milk in TBST

  • 3-5% BSA in TBST (especially beneficial for phosphorylation-specific antibodies)

  • Commercial blocking buffers

• Antibody Dilution: Conduct a titration series (e.g., 1:500, 1:1000, 1:2000, 1:5000) to identify the optimal dilution that maximizes specific signal while minimizing background .

• Washing Protocol Enhancement:

  • Increase the number of washes (at least 3-5 washes)

  • Extend washing times (10-15 minutes each)

  • Add 0.05-0.1% SDS to the wash buffer for stubborn background

• Sample Preparation:

  • Ensure complete denaturation of proteins

  • Remove particulates by centrifugation before loading

  • Consider using protease inhibitors during sample preparation

• Secondary Antibody Considerations: Reduce secondary antibody concentration or switch to more specific secondary antibodies with minimal cross-reactivity to yeast proteins.

What strategies can address poor signal detection in immunofluorescence studies of SPAC16E8.13?

For researchers experiencing weak or absent signals in immunofluorescence:

• Fixation Method Optimization:

  • Compare different fixatives (4% paraformaldehyde, methanol, or combination protocols)

  • Test various fixation times and temperatures

  • For S. pombe, specialized cell wall digestion may be necessary

• Antigen Retrieval:

  • Heat-induced epitope retrieval (citrate buffer, pH 6.0)

  • Enzymatic retrieval (proteinase K treatment)

  • Try different retrieval durations and temperatures

• Signal Amplification:

  • Implement tyramide signal amplification systems

  • Use biotin-streptavidin amplification

  • Consider secondary antibodies with brighter fluorophores

• Permeabilization Adjustment:

  • Test different detergents (Triton X-100, Tween-20, saponin)

  • Optimize detergent concentration and incubation time

  • For S. pombe, enzymatic cell wall digestion may need adjustment

• Microscopy Settings:

  • Increase exposure time (within reasonable limits to avoid photobleaching)

  • Adjust gain settings

  • Consider using confocal microscopy with z-stacking for improved signal detection

What are the common pitfalls in quantifying SPAC16E8.13 expression levels and how can they be addressed?

Accurate quantification of SPAC16E8.13 can be challenging. Consider these strategies:

• Reference Gene Selection:

  • Validate multiple reference genes (e.g., act1+, cdc2+, pda1+) under your experimental conditions

  • Use geometric averaging of multiple references rather than a single housekeeping gene

• Detection Method Limitations:

  • For Western blot quantification, ensure you're working within the linear range of detection

  • Use appropriate loading controls and normalize consistently

  • Consider more quantitative methods like ELISA or quantitative mass spectrometry

• Experimental Variability:

  • Run technical replicates (minimum of three)

  • Include biological replicates from independent experiments

  • Apply appropriate statistical tests to determine significance

• Sample Preparation Consistency:

  • Standardize cell harvesting procedures

  • Use consistent lysis methods

  • Process all samples simultaneously when possible

• Computational Analysis:

  • Develop automated image processing and data analysis pipelines for objective quantification

  • Similar to the chromosome condensation assay optimization mentioned in the literature, computational approaches can reduce variability and increase reproducibility

How should researchers design experiments to investigate potential interactions between SPAC16E8.13 and the nuclear transport machinery?

Given SPAC16E8.13's potential role in regulating nuclear transport , a comprehensive experimental design should include:

• Co-Immunoprecipitation Studies:

  • Use SPAC16E8.13 antibodies to immunoprecipitate the protein complex

  • Perform mass spectrometry analysis to identify interacting partners

  • Confirm key interactions with reverse co-IP using antibodies against identified partners

• Yeast Two-Hybrid Screening:

  • Use SPAC16E8.13 as bait to screen for interacting proteins

  • Focus on known components of nuclear transport machinery

  • Validate positive hits with complementary methods

• Localization Studies:

  • Create fluorescently tagged versions of SPAC16E8.13

  • Perform live-cell imaging under various conditions

  • Co-localize with known nuclear transport components

• Functional Assays:

  • Develop nuclear transport assays using fluorescent reporters

  • Compare transport kinetics in wild-type vs. SPAC16E8.13 deletion or overexpression strains

  • Test effects of specific mutations in SPAC16E8.13

• Genetic Interaction Analysis:

  • Create double mutants with genes involved in nuclear transport

  • Look for synthetic lethality or suppression phenotypes

  • Similar to the genetic interaction analysis performed for zas1 and klf1

What considerations are important when interpreting conflicting data from different SPAC16E8.13 antibody-based experiments?

When facing contradictory results:

• Epitope Differences:

  • Different antibodies may recognize distinct epitopes that could be differentially accessible in various experimental conditions

  • Some epitopes may be masked by protein interactions or post-translational modifications

  • Map the epitopes recognized by each antibody and consider how experimental conditions might affect epitope accessibility

• Antibody Validation Status:

  • Evaluate the validation data for each antibody

  • Consider the validation methods used (knockout controls, peptide competition, etc.)

  • Prioritize results from more extensively validated antibodies

• Experimental Condition Variations:

  • Buffer composition differences can affect antibody-antigen interactions

  • Temperature, incubation time, and pH can all influence results

  • Standardize conditions across experiments when possible

• Cell/Tissue Preparation Methods:

  • Different lysis methods may preserve or disrupt certain protein interactions

  • Fixation methods can affect epitope recognition

  • Consider the biological state of the cells (growth phase, stress conditions, etc.)

• Resolution Strategies:

  • Generate epitope-tagged versions of SPAC16E8.13 as alternative detection methods

  • Use orthogonal, antibody-independent techniques to validate key findings

  • Design experiments that can distinguish between competing hypotheses

How can researchers effectively study the relationship between SPAC16E8.13 and ubiquitin-mediated processes?

Since SPAC16E8.13 is predicted to function as a ubiquitin-protein ligase E3 , the following approaches are recommended:

• In Vitro Ubiquitination Assays:

  • Purify recombinant SPAC16E8.13

  • Test its ability to catalyze ubiquitin transfer in the presence of E1, E2, and ATP

  • Identify specific E2 partners through systematic testing

• Substrate Identification:

  • Perform proteomics analysis comparing ubiquitinated proteins in wild-type vs. SPAC16E8.13 deletion strains

  • Use proximity-based labeling methods (BioID, APEX) to identify proteins in close proximity to SPAC16E8.13

  • Validate candidate substrates through in vitro and in vivo assays

• Domain Function Analysis:

  • Create point mutations in the RING domain and other functional regions

  • Assess the impact on ubiquitination activity

  • Determine if mutations affect localization or protein interactions

• Temporal Regulation Studies:

  • Analyze SPAC16E8.13 activity across the cell cycle

  • Investigate responses to cellular stresses

  • Examine potential regulation by post-translational modifications

• Integration with Nuclear Transport Function:

  • Determine if ubiquitination by SPAC16E8.13 regulates nuclear transport

  • Identify if components of the nuclear transport machinery are substrates

  • Similar to studies showing Zas1's role in enhancing transcription of condensin subunit cnd1

How might computational approaches enhance antibody-based studies of SPAC16E8.13?

Advanced computational methods can significantly improve research outcomes:

• Automated Image Analysis Pipelines:

  • Develop specialized algorithms for quantifying immunofluorescence signals

  • Implement machine learning approaches for pattern recognition

  • Create standardized workflows for reproducible analysis across laboratories

  • Similar to the computational pipeline developed for chromosome condensation assays

• Epitope Prediction and Antibody Design:

  • Use computational tools to identify optimal epitopes for antibody generation

  • Predict potential cross-reactivity with related proteins

  • Design epitopes that are accessible in native protein conformations

• Structural Biology Integration:

  • Use antibody binding data to inform structural models of SPAC16E8.13

  • Predict functional domains and interaction surfaces

  • Guide mutagenesis studies to test structural predictions

• Systems Biology Approaches:

  • Integrate antibody-derived localization and interaction data into network models

  • Predict functional relationships based on correlation analyses

  • Generate testable hypotheses about SPAC16E8.13 function in cellular processes

• Standardization and Data Sharing:

  • Develop repositories for antibody validation data

  • Create standardized reporting formats for antibody-based experiments

  • Implement FAIR (Findable, Accessible, Interoperable, Reusable) principles for antibody research

What methodological advances could improve the study of SPAC16E8.13 post-translational modifications?

Understanding post-translational modifications (PTMs) of SPAC16E8.13 requires specialized approaches:

• PTM-Specific Antibody Development:

  • Generate antibodies against predicted phosphorylation, ubiquitination, or other PTM sites

  • Validate specificity using site-directed mutagenesis

  • Apply similar validation principles as used for SPARC-related modular calcium-binding protein 1 (SMOC-1) antibodies

• Mass Spectrometry Protocols:

  • Optimize enrichment strategies for phosphopeptides, ubiquitinated peptides, etc.

  • Implement targeted mass spectrometry approaches for specific PTMs

  • Develop quantitative methods to assess PTM dynamics

• In vivo Labeling Techniques:

  • Apply metabolic labeling to track PTM incorporation

  • Use proximity labeling to identify enzymes responsible for specific modifications

  • Implement FRET-based sensors to monitor PTM dynamics in live cells

• Site-Specific Mutagenesis:

  • Create comprehensive libraries of PTM site mutants

  • Analyze phenotypic consequences of mutation

  • Identify functionally important modification sites

• Temporal Analysis:

  • Study PTM dynamics throughout the cell cycle

  • Examine responses to cellular stresses

  • Monitor changes during developmental processes